SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0000902664-23-001919
Filing Date
2023-02-17
Accepted
2023-02-17 16:35:11
Documents
1

Document Format Files

Seq Description Document Type Size
1 IOVANCE BIOTHERAPEUTICS, INC. p23-0960sc13g.htm SC 13G 83827
  Complete submission text file 0000902664-23-001919.txt   85635
Mailing Address 825 INDUSTRIAL ROAD 4TH FLOOR SAN CARLOS CA 94070
Business Address 825 INDUSTRIAL ROAD 4TH FLOOR SAN CARLOS CA 94070 6502607120
IOVANCE BIOTHERAPEUTICS, INC. (Subject) CIK: 0001425205 (see all company filings)

IRS No.: 753254381 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-85384 | Film No.: 23643219
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address 72 CUMMINGS POINT ROAD STAMFORD CT 06902
Business Address 72 CUMMINGS POINT ROAD STAMFORD CT 06902 203-890-2000
Point72 Asset Management, L.P. (Filed by) CIK: 0001603466 (see all company filings)

IRS No.: 465064661 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G